Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes-Reference-Cited by-同舟云学术

Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes

Published:2016-06 Issue:6 Volume:15 Page:2076-2092
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Osinalde Nerea,Mitxelena Jone,Sánchez-Quiles Virginia,Akimov Vyacheslav,Aloria Kerman,Arizmendi Jesus M.,Zubiaga Ana M.,Blagoev Blagoy,Kratchmarova Irina

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference77 articles.

1. Adoptive immunotherapy for cancer: harnessing the T cell response;Restifo;Nat. Rev. Immunol,2012

2. Combining immunotherapy and targeted therapies in cancer treatment;Vanneman;Nat. Rev. Cancer,2012

3. IL-2: the first effective immunotherapy for human cancer;Rosenberg;J. Immunol,2014

4. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy;Fyfe;J. Clin. Oncol,1995

5. Bcl-2 overexpression enhances tumor-specific T-cell survival;Charo;Cancer Res,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo;Gut;2024-01-04

2. Unraveling the mechanisms of various phospho-proteomics approach for crop improvement;Current Omics Advancement in Plant Abiotic Stress Biology;2024

3. Targeting dysregulated lipid metabolism in the tumor microenvironment;Archives of Pharmacal Research;2023-12

4. The dual role of citrate in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Therapeutic targeting of ACLY in T-ALLin vivo;2023-03-28